| Analysis | Metabolite Name | Measured Value | Units | Model | Intervention |
|---|---|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.0085 | peak area | Alzheimer’s disease model | Saline |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.0094 | peak area | Alzheimer’s disease model | Saline |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.011 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.011 | peak area | Alzheimer’s disease model | Saline |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.011 | peak area | Wild type | B. breve MCC1274 |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.011 | peak area | Wild type | Saline |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.012 | peak area | Wild type | B. breve MCC1274 |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.012 | peak area | Wild type | Saline |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.013 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.013 | peak area | Wild type | B. breve MCC1274 |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.013 | peak area | Wild type | Saline |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.014 | peak area | Alzheimer’s disease model | Saline |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.015 | peak area | Wild type | Saline |
| Reversed phase UNSPECIFIED ION MODE | Palmitic acid | 0.020 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|